UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease

Nature genetics, 2009-12, Vol.41 (12), p.1303-1307

2009

Volltextzugriff (PDF)

LRRK2 directly phosphorylates Akt1 as a possible physiological substrate: Impairment of the kinase activity by Parkinson’s disease-associated mutations

FEBS letters, 2011-07, Vol.585 (14), p.2165-2170

2011

Volltextzugriff (PDF)

LRRK2 phosphorylates tubulin-associated tau but not the free molecule: LRRK2-mediated regulation of the tau-tubulin association and neurite outgrowth

PloS one, 2012-01, Vol.7 (1), p.e30834-e30834

2012

Volltextzugriff (PDF)

Leucine-Rich Repeat Kinase 2 Controls Inflammatory Cytokines Production through NF-κB Phosphorylation and Antigen Presentation in Bone Marrow-Derived Dendritic Cells

International journal of molecular sciences, 2020-03, Vol.21 (5), p.1890

2020

Volltextzugriff (PDF)

A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1

Annals of neurology, 2002-03, Vol.51 (3), p.296-301

2002

Volltextzugriff (PDF)

An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family

Annals of neurology, 2005-06, Vol.57 (6), p.918-921

2005

Volltextzugriff (PDF)

Dominant-negative effects of LRRK2 heterodimers: A possible mechanism of neurodegeneration in Parkinson’s disease caused by LRRK2 I2020T mutation

Biochemical and biophysical research communications, 2013-01, Vol.430 (2), p.560-566

2013

Volltextzugriff (PDF)

Leucine-rich repeat kinase 2 is a regulator of B cell function, affecting homeostasis, BCR signaling, IgA production, and TI antigen responses

Journal of neuroimmunology, 2016-03, Vol.292, p.1-8

2016

Volltextzugriff (PDF)

Generation of gene-corrected iPSCs line (KEIUi001-A) from a PARK8 patient iPSCs with familial Parkinson’s disease carrying the I2020T mutation in LRRK2

Stem cell research, 2020-12, Vol.49, p.102073-102073, Article 102073

2020

Volltextzugriff (PDF)

Prevention of intracellular degradation of I2020T mutant LRRK2 restores its protectivity against apoptosis

Biochemical and biophysical research communications, 2010-01, Vol.391 (1), p.242-247

2010

Volltextzugriff (PDF)

The I2020T Leucine-rich repeat kinase 2 transgenic mouse exhibits impaired locomotive ability accompanied by dopaminergic neuron abnormalities

Molecular neurodegeneration, 2012-04, Vol.7 (1), p.15-15, Article 15

2012

Volltextzugriff (PDF)

Enhanced activated Tï¿½cell subsets in prostate cancer patients receiving iodine-125 low-dose-rate prostate brachytherapy

Oncology reports, 2017-11

2017

Volltextzugriff (PDF)

Independent occurrence of I2020T mutation in the kinase domain of the leucine rich repeat kinase 2 gene in Japanese and German Parkinson's disease families

Neuroscience letters, 2007-04, Vol.417 (1), p.21-23

2007

Volltextzugriff (PDF)

Establishment of DYT5 patient-specific induced pluripotent stem cells with a GCH1 mutation

Stem cell research, 2017-10, Vol.24 (C), p.36-39

2017

Volltextzugriff (PDF)

I2020T leucine-rich repeat kinase 2, the causative mutant molecule of familial Parkinson’s disease, has a higher intracellular degradation rate than the wild-type molecule

Biochemical and biophysical research communications, 2009-12, Vol.390 (3), p.710-715

2009

Volltextzugriff (PDF)

Expression of Stress-related Genes in a Cadmium-resistant A549 Human Cell Line

Journal of Toxicology and Environmental Health, Part A, 2005-05, Vol.68 (9), p.703-718

2005

Volltextzugriff (PDF)

Leucine-rich repeat kinase 2 (LRRK2) regulates α-synuclein clearance in microglia

BMC neuroscience, 2016-11, Vol.17 (1), p.77-77, Article 77

2016

Volltextzugriff (PDF)

I2020T mutant LRRK2 iPSC-derived neurons in the Sagamihara family exhibit increased Tau phosphorylation through the AKT/GSK-3β signaling pathway

Human molecular genetics, 2015-09, Vol.24 (17), p.4879-4900

2015

Volltextzugriff (PDF)

Enhanced activated T cell subsets in prostate cancer patients receiving iodine-125 low-dose-rate prostate brachytherapy

Oncology reports, 2018-01, Vol.39 (1), p.417-424

2018

Volltextzugriff (PDF)

Age-dependent and cell-population-restricted LRRK2 expression in normal mouse spleen

Biochemical and biophysical research communications, 2010-02, Vol.392 (3), p.431-435

2010

Volltextzugriff (PDF)

Pathogenesis of Parkinson's disease through LRRK2 mutation

Seikagaku. The Journal of Japanese Biochemical Society, 2014-02, Vol.86 (1), p.92

2014

Volltextzugriff (PDF)

LRRK2 is expressed in B-2 but not in B-1 B cells, and downregulated by cellular activation

Journal of neuroimmunology, 2010-12, Vol.229 (1), p.123-128

2010

Volltextzugriff (PDF)

The CD14 Monocyte Differentiation Antigen Maps to a Region Encoding Growth Factors and Receptors

Science (American Association for the Advancement of Science), 1988-01, Vol.239 (4839), p.497-500

1988

Volltextzugriff (PDF)

Clinicogenetic study of mutations inLRRK2 exon 41 in Parkinson's disease patients from 18 countries

Movement disorders, 2006-08, Vol.21 (8), p.1102-1108

2006

Volltextzugriff (PDF)

Allo-antigen stimulated CD8+ T-cells suppress NF-κB and Ets-1 DNA binding activity, and inhibit phosphorylated NF-κB p65 nuclear localization in CD4+ T-cells

Viral immunology, 2014-08, Vol.27 (6), p.305-315

2014

Volltextzugriff (PDF)

1 – 25 von 92

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(75)

Publikationsform

Sprache

Englisch
(89)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(56)
Life Sciences & Biomedicine
(50)
Humans
(44)
Biological And Medical Sciences
(25)
Fundamental And Applied Biological Sciences. Psychology
(17)
Animals
(16)
Immunology
(16)
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
(15)
Biochemistry & Molecular Biology
(13)
Molecular Sequence Data
(13)
Protein-Serine-Threonine Kinases - Genetics
(13)
Base Sequence
(12)
Female
(12)
Neurosciences & Neurology
(12)
Parkinson Disease - Genetics
(12)
Amino Acid Sequence
(11)
Japan
(11)
Male
(11)
Medical Sciences
(11)
Mutation
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease

LRRK2 directly phosphorylates Akt1 as a possible physiological substrate: Impairment of the kinase activity by Parkinson’s disease-associated mutations

LRRK2 phosphorylates tubulin-associated tau but not the free molecule: LRRK2-mediated regulation of the tau-tubulin association and neurite outgrowth

Leucine-Rich Repeat Kinase 2 Controls Inflammatory Cytokines Production through NF-κB Phosphorylation and Antigen Presentation in Bone Marrow-Derived Dendritic Cells

A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1

An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family

Dominant-negative effects of LRRK2 heterodimers: A possible mechanism of neurodegeneration in Parkinson’s disease caused by LRRK2 I2020T mutation

Leucine-rich repeat kinase 2 is a regulator of B cell function, affecting homeostasis, BCR signaling, IgA production, and TI antigen responses

Generation of gene-corrected iPSCs line (KEIUi001-A) from a PARK8 patient iPSCs with familial Parkinson’s disease carrying the I2020T mutation in LRRK2

Prevention of intracellular degradation of I2020T mutant LRRK2 restores its protectivity against apoptosis

The I2020T Leucine-rich repeat kinase 2 transgenic mouse exhibits impaired locomotive ability accompanied by dopaminergic neuron abnormalities

Enhanced activated Tï¿½cell subsets in prostate cancer patients receiving iodine-125 low-dose-rate prostate brachytherapy

Independent occurrence of I2020T mutation in the kinase domain of the leucine rich repeat kinase 2 gene in Japanese and German Parkinson's disease families

Establishment of DYT5 patient-specific induced pluripotent stem cells with a GCH1 mutation

I2020T leucine-rich repeat kinase 2, the causative mutant molecule of familial Parkinson’s disease, has a higher intracellular degradation rate than the wild-type molecule

Expression of Stress-related Genes in a Cadmium-resistant A549 Human Cell Line

Leucine-rich repeat kinase 2 (LRRK2) regulates α-synuclein clearance in microglia

I2020T mutant LRRK2 iPSC-derived neurons in the Sagamihara family exhibit increased Tau phosphorylation through the AKT/GSK-3β signaling pathway

Enhanced activated T cell subsets in prostate cancer patients receiving iodine-125 low-dose-rate prostate brachytherapy

Age-dependent and cell-population-restricted LRRK2 expression in normal mouse spleen

Pathogenesis of Parkinson's disease through LRRK2 mutation

LRRK2 is expressed in B-2 but not in B-1 B cells, and downregulated by cellular activation

The CD14 Monocyte Differentiation Antigen Maps to a Region Encoding Growth Factors and Receptors

Clinicogenetic study of mutations inLRRK2 exon 41 in Parkinson's disease patients from 18 countries

Allo-antigen stimulated CD8+ T-cells suppress NF-κB and Ets-1 DNA binding activity, and inhibit phosphorylated NF-κB p65 nuclear localization in CD4+ T-cells

Suchergebnisse filtern